Priming with Toll-like receptor 3 agonist or interferon-gamma enhances the therapeutic effects of human mesenchymal stem cells in a murine model of atopic dermatitis

Title
Priming with Toll-like receptor 3 agonist or interferon-gamma enhances the therapeutic effects of human mesenchymal stem cells in a murine model of atopic dermatitis
Authors
Keywords
Mesenchymal stem cells, Priming, Atopic dermatitis, Toll-like receptor 3 agonist, Interferon-γ
Journal
Stem Cell Research & Therapy
Volume 10, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-02-22
DOI
10.1186/s13287-019-1164-6

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started